Aller au contenu principal
Profil bibliographique

Nazareno Roberto Suardi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

772Publications signalées
16732Citations signalées
0Affiliations récentes

Les domaines associés

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentMultiple and Secondary Primary Cancers

Les publications récentes

2025 article OpenAlex

Temporal trends and clinical determinants of urinary diversion after radical cystectomy

Francesco Pellegrino, Mario de Angelis, Pietro Scilipoti, Mattia Longoni et autres

OBJECTIVES: To evaluate the temporal trends in types of urinary diversion (UD) used after radical cystectomy (RC) in a large, multicentre, international cohort over the past two decades. MATERIALS AND METHODS: We analysed 6469 patients who underwent RC between 2004 and 2024 …

us, it, be, fr, es, ch, at, jp, my, de, hk, nl, pl, cz, ca (code pays fourni par la source)

6 citations British Journal of Urology
Accès ouvert 2025 article OpenAlex

UrOP position paper in support of the new classification of urinary tract infections: from “uncomplicated/complicated” to localized/systemic”

Guglielmo Mantica, Stefano Alba, Andrea Alfarone, Umberto Capitanio et autres

Dear Editor, For a few decades, urinary tract infections (UTIs) have been classified according to the dichotomy "uncomplicated" and "complicated"...

it, br (code pays fourni par la source)

0 citations Archivio Italiano di Urologia e Andrologia
Accès ouvert 2025 conference-abstract OpenAlex

P36 - Adavosertib-mediated wee1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models

Mariangela Tamburello, C Depetris de Boldini, Andrea Abate, Valentina Salvi et autres

Abstract Background/Introduction Testicular germ cell tumors (TGCTs) are the most common solid malignancy in young adult males with non-seminomatous representing a clinically aggressive subtype. Although cisplatin (CP)-based chemotherapy is highly effective, with cure rates exceeding 95%, a subset of patients develop resistance. …

us, it, ca, de (code pays fourni par la source)

0 citations European Journal of Endocrinology
Accès ouvert 2025 article OpenAlex

Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study

Mattia Longoni, Pietro Scilipoti, Mario de Angelis, Paolo Zaurito et autres

OBJECTIVE: To report real-world rates of non-muscle-invasive bladder cancer (NMIBC) recurrence and progression within a European multicentre cohort with detailed information on intravesical instillation courses, as contemporary data on oncological outcomes in NMIBC are limited. PATIENTS AND METHODS: A total of 1918 …

it, ca, fr, es, pl (code pays fourni par la source)

24 citations British Journal of Urology
Accès ouvert 2025 article OpenAlex

Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study

Martina Buffoni, Alberto Dalla Volta, Francesca Valcamonico, Marco Bergamini et autres

BACKGROUND AND OBJECTIVE: The reduction of lean body mass (LBM) and the increase of fat body mass (FBM) caused by androgen deprivation therapy (ADT) administered to prostate cancer patients are well known to lead to an increased risk of sarcopenia. The effects …

it (code pays fourni par la source)

5 citations European Urology Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.